Mikel Mikhail1, Andre Ali-Ridha2, Sarah Chorfi3, Michael A Kapusta2. 1. Department of Ophthalmology, Jewish General Hospital, McGill University, 3755 Côte-Ste-Catherine Road, Montreal, Québec, H3T1E2, Canada. mikel.mikhail@mail.mcgill.ca. 2. Department of Ophthalmology, Jewish General Hospital, McGill University, 3755 Côte-Ste-Catherine Road, Montreal, Québec, H3T1E2, Canada. 3. Department of Ophthalmology, Université de Montréal, Montreal, QC, Canada.
Abstract
PURPOSE: To evaluate the short- and long-term surgical and clinical outcomes in eyes with diabetic tractional retinal detachment (TRD) undergoing 25-G+ pars-plana vitrectomy (PPV). METHODS: A total of 238 patients were reviewed for inclusion in this study. A retrospective cohort study of 109 eyes of 73 patients operated on for diabetic TRD were included. All eyes received intraocular tamponade of air, sulfur hexafluoride, octofluropropane or silicone oil. All patients were followed up for a minimum period of one year. RESULTS: The mean age of all patients at surgery was 53.9 years ± 9.2, while the mean duration of diabetes was 18.7 ± 10.4 years. The mean length of follow-up was 923 ± 87 days after surgery (range, 432-1792 days). Thirty-two cases (29.3 %) had an associated rhegmatogenous component. Mean BCVA improved from logarithm minimum angle of resolution (logMAR) 1.17 (20/300) to 0.812 (20/130) (p < 0.05). All eyes underwent intraoperative laser photocoagulation. Primary, single-surgery anatomic reattachment was achieved in 99 eyes (91 %). Final anatomic attachment was achieved in 107 eyes (98 %). There was no statistically significant difference in primary or secondary re-attachment rate in terms of type of tamponade agent used. There were five cases of post-operative hypotony (≤5 mmHg) on postoperative day 1, while 11 eyes had IOP ≥ 30 mmHg. There were no cases of endophthalmitis in our cohort. CONCLUSIONS: 25G+ PPV provides for safe and effective repair of diabetic TRDs. Patients experienced positive functional and anatomic outcomes, with no significant intraoperative complications and minimal postoperative sequelae.
PURPOSE: To evaluate the short- and long-term surgical and clinical outcomes in eyes with diabetic tractional retinal detachment (TRD) undergoing 25-G+ pars-plana vitrectomy (PPV). METHODS: A total of 238 patients were reviewed for inclusion in this study. A retrospective cohort study of 109 eyes of 73 patients operated on for diabetic TRD were included. All eyes received intraocular tamponade of air, sulfur hexafluoride, octofluropropane or silicone oil. All patients were followed up for a minimum period of one year. RESULTS: The mean age of all patients at surgery was 53.9 years ± 9.2, while the mean duration of diabetes was 18.7 ± 10.4 years. The mean length of follow-up was 923 ± 87 days after surgery (range, 432-1792 days). Thirty-two cases (29.3 %) had an associated rhegmatogenous component. Mean BCVA improved from logarithm minimum angle of resolution (logMAR) 1.17 (20/300) to 0.812 (20/130) (p < 0.05). All eyes underwent intraoperative laser photocoagulation. Primary, single-surgery anatomic reattachment was achieved in 99 eyes (91 %). Final anatomic attachment was achieved in 107 eyes (98 %). There was no statistically significant difference in primary or secondary re-attachment rate in terms of type of tamponade agent used. There were five cases of post-operative hypotony (≤5 mmHg) on postoperative day 1, while 11 eyes had IOP ≥ 30 mmHg. There were no cases of endophthalmitis in our cohort. CONCLUSIONS: 25G+ PPV provides for safe and effective repair of diabetic TRDs. Patients experienced positive functional and anatomic outcomes, with no significant intraoperative complications and minimal postoperative sequelae.
Authors: Anderson Teixeira; Lawrence P Chong; Naoki Matsuoka; Luis Arana; Ralph Kerns; Prashant Bhadri; Mark Humayun Journal: Ophthalmology Date: 2010-02-21 Impact factor: 12.079
Authors: M Ali Khan; Abtin Shahlaee; Brian Toussaint; Jason Hsu; Arunan Sivalingam; Pravin U Dugel; Rohit R Lakhanpal; Christopher D Riemann; Maria H Berrocal; Carl D Regillo; Allen C Ho Journal: Am J Ophthalmol Date: 2015-09-28 Impact factor: 5.258
Authors: Rohit R Lakhanpal; Mark S Humayun; Eugene de Juan; Jennifer I Lim; Lawrence P Chong; Tom S Chang; Michael Javaheri; Gildo Y Fujii; Aaron C Barnes; Terry J Alexandrou Journal: Ophthalmology Date: 2005-05 Impact factor: 12.079
Authors: Mikel Mikhail; Andre Ali-Ridha; Sarah Chorfi; Michael A Kapusta Journal: Graefes Arch Clin Exp Ophthalmol Date: 2017-07-15 Impact factor: 3.117
Authors: Jared T Sokol; Sidney A Schechet; Darin T Rosen; Kevin Ferenchak; Sherif Dawood; Dimitra Skondra Journal: PLoS One Date: 2019-08-20 Impact factor: 3.240
Authors: Aaron Ricca; Kiley Boone; H Culver Boldt; Karen M Gehrs; Stephen R Russell; James C Folk; M Bridget Zimmerman; Mark E Wilkinson; Elliott H Sohn Journal: Sci Rep Date: 2020-09-24 Impact factor: 4.379